MDMs also release IL-6 and IL-1β, which respectively activate phosphoglycerate kinase 1 via the 3-phosphoinositide-dependent protein kinase 1 pathway and glycerol-3-phosphate dehydrogenase through the PI3K/PKCδ pathway in GBM cells [34]. The gene discussed is IL6; the disease is glioblastoma.